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Xmc Mediates Xctr1-Independent
Morphogenesis in Xenopus laevis†
Tomomi Haremaki and Daniel C. Weinstein*
In the frog, Xenopus laevis, ﬁbroblast growth factor (FGF) signaling is required for both mesoderm
formation and the morphogenetic movements that drive the elongation of the notochord, a dorsal
mesodermal derivative; the coordination of these distinct roles is mediated by the Xenopus Ctr1 (Xctr1)
protein: maternal Xctr1 is required for mesodermal differentiation, while the subsequent loss of Xctr1
promotes morphogenesis. The signaling cascade activated by FGF in the presence of Ctr1 has been well
characterized; however, the Xctr1-independent, FGF-responsive network remains poorly deﬁned. We have
identiﬁed Xenopus Marginal Coil (Xmc) as a gene whose expression is highly enriched following Xctr1
knockdown. Zygotic initiation of Xmc expression in vivo coincides with a decrease in maternal Xctr1
transcripts; moreover, Xmc loss-of-function inhibits Xctr1 knockdown-mediated elongation of FGF-treated
animal cap explants, implicating Xmc as a key effector of Xctr1-independent gastrular morphogenesis.
Developmental Dynamics 238:2382–2387, 2009. © 2009 Wiley-Liss, Inc.
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INTRODUCTION
Vertebrate development is driven largely
by inductive interactions, during which
one group of cells inﬂuences the fate of
another, often by means of the activity of
secreted extracellular ligands. A striking
feature of embryonic induction is the
prominence of a small set of ligands in
these varied interactions, from germ
layer formation and early patterning to
morphogenesis and organogenesis. This
observation raises an important question
regarding signal interpretation; that is,
how does the embryo ensure that a given
signal elicits a response that is speciﬁc,
and biologically appropriate, to the re-
sponding cell? At least two distinct sce-
narios are plausible. On the one hand,
one could envision that a single “core”
pathway induced by a given ligand
could be modiﬁed, at or near the cas-
cade’s terminus, by a set of transcrip-
tional effectors speciﬁc to one or a few
cell types. Alternatively, a single li-
gand-receptor pair could induce largely
distinct signaling cascades, depending
upon the cellular context in which the
induction takes place.
Members of the ﬁbroblast growth
factor (FGF) family play a critical role
during innumerable steps of embryo-
genesis. In the frog, Xenopus laevis,
FGF is essential for maintaining the
differentiation of the mesodermal
germ layer, ﬁrst induced by trans-
forming growth factor- (TGF) sig-
naling (Heasman, 2006). Shortly after
the initiation of gastrulation, FGF re-
ceptor activation no longer supports
mesodermal differentiation; instead,
FGF signaling promotes the dramatic
lengthening of both the notochord, a
dorsal mesodermal derivative, and the
caudal neural tube, by means of the
morphogenetic processes of conver-
gence and extension (Nutt et al.,
2001). FGF mediated-mesoderm in-
duction results from activation of the
“canonical” Ras/MAPK cascade (Heas-
man, 2006); FGF-mediated morpho-
genesis, however, results instead from
the activation of Ras/MAPK-indepen-
dent “noncanonical” FGF signaling
(Nutt et al., 2001). These distinct
FGF-dependent pathways are distin-
guished not only by their activating
components, but by their distinct re-
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pressors, as well: the Xenopus Spred
proteins block Ras/MAPK signaling;
while the related Sprouty proteins in-
hibit Ca2 and PKC “noncanonical”
signaling (Sivak et al., 2005). Thus,
the shift in the biological consequence
of FGF signaling is due to a shift in
the signaling cascades stimulated by
FGF receptor activation.
A key mechanism by which early
embryonic cells “translate” FGF re-
ceptor activity into a speciﬁc signaling
cascade and subsequent biological ac-
tivity hinges on the presence or ab-
sence of the Ctr1 protein within the
plasma membrane-associated FGF
signaling complex. The maternal Xe-
nopus Ctr1 (Xctr1) protein facilitates
phosphorylation of the FGF receptor-
associated docking protein SNT-1/
FRS2 by the FGF receptor and the
Laloo nonreceptor tyrosine kinases, as
well as the phosphorylation and acti-
vation of ERK, the latter event a de-
ﬁning step in “canonical” FGF signal-
ing (Hama et al., 2001; Heasman,
2006; Haremaki et al., 2007). Consis-
tent with this biochemical activity,
Xctr1 misexpression enhances FGF-
mediated mesoderm induction, and
inhibits convergent extension, both in
explants and in vivo (Haremaki et al.,
2007). Conversely, loss of Xctr1 inhib-
its mesoderm differentiation and in-
stead promotes mesodermal and neu-
ral morphogenesis (Haremaki et al.,
2007).
While it is clear that loss of Xctr1
both inhibits differentiation and pro-
motes gastrular morphogenesis, little
is yet known of the “noncanonical” sig-
naling cascade that is activated by
FGF in the absence of Xctr1. In an
attempt to address the mechanisms
by which Xctr1 elimination promotes
coordinated tissue movements, we
performed gene array studies to iden-
tify transcripts that were robustly en-
riched by FGF in the absence of Xctr1.
We have identiﬁed several genes that
are highly expressed following Xctr1
knockdown. One of these, Xenopus
Marginal Coil (Xmc), a gene previ-
ously described as an FGF-responsive
transcript, was selected for further
study (Frazzetto et al., 2002). Xmc ex-
pression initiates shortly after the ini-
tial clearing of maternal Xctr1 tran-
scripts in the Xenopus embryo, and
Xmc loss-of-function inhibits Xctr1
knockdown-mediated elongation by
FGF, indicating that Xmc is necessary
for FGF-stimulated, Xctr1-indepen-
dent morphogenesis.
RESULTS
We have previously demonstrated
that Xctr1 loss-of-function promotes
FGF-mediated elongation of Xenopus
explant cultures (Haremaki et al.,
2007). While several signaling compo-
nents have been implicated in caudal
neural and dorsal mesodermal mor-
phogenesis, little is known about the
regulation of these events at the level
of gene expression. To characterize
the transcriptional response to Xctr1
knockdown, we performed microarray
analyses to compare the expression
proﬁles of FGF-treated animal caps
from embryos injected with either
Xctr1-speciﬁc (Xctr1MO) or 5-base
pair mismatch- (Xctr1MM) morpholi-
nos; Xctr1MM does not inhibit Xctr1
translation, in vitro (Haremaki et al.,
2007). A representative experiment is
shown in Figure 1; the lack of effect on
“housekeeping” genes (e.g., EF1-a)
and the reduction of dorsal mesoderm-
speciﬁc genes (e.g., muscle actin) fol-
lowing Xctr1 knockdown point to the
quality of these data sets (Fig. 1; Mo-
hun et al., 1984; Krieg et al., 1989).
Our aim in these studies was to iden-
tify genes whose expression was
strongly induced following Xctr1 knock-
down. We reasoned that, because both
neural and mesodermal differentiation
were inhibited by Ctr1 elimination, the
genes we identiﬁed as “up-regulated” in
our analysis were not likely to represent
molecular markers of induced cell fates
and were, thus, reasonable candidate
effectors of Ctr1 knockdown-mediated
morphogenesis. We identiﬁed 25 anno-
tated genes with greater than threefold
elevated expression, following Xctr1
knockdown in FGF-treated neurula
stage animal cap explants, in each of
two independent microarray experi-
ments (Table 1). Candidates selected for
independent veriﬁcation were con-
ﬁrmed by reverse transcriptase-poly-
merase chain reaction (RT-PCR; Table
1, bold, Fig. 2, and data not shown).
Strikingly, exogenous FGF was not re-
quired for enhanced expression of these
transcripts; knockdown of Xctr1 was
alone sufﬁcient to stimulate this re-
sponse (Fig. 2).
To narrow the pool of candidate effec-
tors, we reasoned that mediators of
Xctr1-independent morphogenesis might
also show a reduction in transcript
abundance following Xctr1 misexpres-
sion, as Xctr1 inhibits elongation of
both dorsal mesoderm and caudal
neurectoderm (Haremaki et al., 2007).
We therefore performed an additional
microarray study to select for tran-
scripts down-regulated by Xctr1 in an-
imal cap explants. Figure 3A shows
the effects of Xctr1 misexpression on
transcripts shown to be up-regulated
in the Xctr1 knockdown microarray
studies. Of the transcripts enriched
following injection of Xctr1 morpho-
lino oligos (Fig. 3A, left panel, red),
only two were signiﬁcantly down-reg-
ulated following misexpression of
Xctr1 RNA (Fig. 3A, right panel, ar-
rows pointing to bright green bands).
Both of these bands correspond to Xe-
nopus marginal coil (Xmc). The FGF-
inducible Xmc gene encodes a coiled-
coil protein previously implicated in
the regulation of gastrulation move-
ments (Frazzetto et al., 2002); it was
thus chosen for further analysis. RT-
PCR was used to conﬁrm that Xctr1
knockdown enhances Xmc expression
in the presence of FGF (Fig. 3B). Xmc
transcripts are also enriched following
Xctr1 knockdown in the absence of
FGF (Fig. 3C). We next conﬁrmed, us-
ing RT-PCR, that Xctr1 misexpression
down-regulates Xmc in animal caps
(Fig. 3D,E, lanes 1 and 2). FGF pro-
tein induces robust expression of Xmc
in animal cap explants, presumably
reﬂecting mesodermal Xmc expres-
sion; Activin protein induces levels
similar to those seen with FGF (Fig.
3E, compare lanes 2, 3, and 5;
Frazzetto et al., 2002). Ectopic Xctr1
does not, however, inhibit Xmc expres-
sion in either FGF- or Activin-treated
caps (Fig. 3E). These data demon-
strate that Xctr1 loss-of-function en-
hances Xmc expression in both ecto-
derm and mesoderm, and that Xctr1
gain-of-function suppresses Xmc ex-
pression in ectoderm, but not meso-
derm.
Our studies suggest that Xctr1
knockdown may promote morphogen-
esis by means of induction of Xmc.
Consistently, we ﬁnd that initiation of
Xmc expression coincides with the de-
cline in maternal Xctr1 expression
(Fig. 4; Frazzetto et al., 2002; Hare-
maki et al., 2007). Coupled with the
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gain- and loss-of-function analyses de-
scribed above, these correlative data
provide further evidence for regula-
tion of Xmc by Xctr1, in vivo.
We observed no effects on cell fate
determination or morphogenesis from
Xmc misexpression in ectodermal or
mesodermal explants, including ani-
mal caps treated with FGF and/or Ac-
tivin, or in intact Xenopus embryos,
consistent with earlier published
studies (data not shown; Frazzetto et
al., 2002), suggesting that Xmc gain-
of-function is not sufﬁcient to alter
morphogenesis. We next sought to ad-
dress the potential requirement for
Xmc in mediating Xctr1-independent
morphogenesis. Knockdown of Xmc
function by means of Xmc-speciﬁc an-
tisense morpholino oligonucleotides
has been shown to affect axial elonga-
tion in Xenopus (Frazzetto et al.,
2002); morpholino studies were thus
used to further address the relation-
ship between Xmc and Xctr1 during
Fig. 1. Microarray analysis of Xctr1 knockdown. Data shown are from a representative Affymatrix
gene chip hybridization; signal strength was visualized using Affymetrix GeneChip Operating
Software 1.4. Transcripts that register hybridization signal with both probes (“Xctr1MO and
”Xctr1MM“) are shown in red. Transcripts that register ”absent“ or ”marginal“ hybridization signal
with one probe are shown in blue; transcripts that register ”absent“ or ”marginal“ hybridization
signal with both probes are shown in yellow. Examples of unaffected (EF1-) and down-regulated
(Muscle actin) transcripts are highlighted (arrows); number  fold change.
Fig. 2. Conﬁrmation of genes with elevated
transcription following Xctr1 knockdown. Re-
verse transcriptase-polymerase chain reaction
(RT-PCR) analysis of gene expression in stage
22 animal cap explants. Injection protocol
and/or culture conditions are shown at top. A
total of 10 ng/ml basic ﬁbroblast growth factor
(bFGF) was added, as shown. A total of 250 ng
of Xctr1 morpholino (Xctr1MO) and 250 ng of
Xctr1 mismatch morpholino (Xctr1MM) were in-
jected, as shown. The induction by HoxB9, a
marker of lateral plate mesoderm and spinal
cord at this stage, demonstrates that FGF is
active in this experiment (Wright et al., 1990).
The “RT” lane contains all reagents except
reverse transcriptase and was used as a nega-
tive control. Ornithine decarboxylase (ODC) is
used as a loading control (Bassez et al., 1990).
Fig. 3. Regulation of Xmc by Xctr1. A: Xmc expression is suppressed by Xctr1. Microarray
analysis of gene expression in embryos injected with RNA encoding either Xctr1 or -galactosidase.
Left column: genes that are expressed more highly in ﬁbroblast growth factor (FGF) treated caps
taken from Xctr1MO injected embryos than in FGF treated caps taken from Xctr1MM injected
embryos. Right column: Relative expression of genes from left column in animal caps from embryos
injected with either Xctr1 or -gal RNA. Up-regulated genes are shown in red; down-regulated
genes are shown in green. Arrows point to two transcripts that are strongly down-regulated by
Xctr1 (top: 38%, bottom: 28% of signal in -galactosidase-injected control samples); both tran-
scripts encode Xmc. B–E: Reverse transcriptase-polymerase chain reaction (RT-PCR) conﬁrmation
of microarray data presented in A. B: Xmc expression is elevated following Xctr1 knockdown in
FGF-treated animal caps. C: Xmc expression is elevated following Xctr1 knockdown in animal caps
cultured in saline. D: Xmc expression is suppressed following Xctr1 misexpression in animal caps.
E: Xctr1 does not inhibit Xmc induction by either FGF or Activin protein. Ectopic Xctr1 inhibited
Activin-mediated cap elongation in these assays (data not shown). A total of 10 ng/ml bFGF, 0.5
ng/ml Activin was added, as shown. A total of 250 ng of Xctr1 morpholino (Xctr1MO) and 250 ng
of Xctr1 mismatch morpholino (Xctr1MM) were injected, as shown. Also, 1 ng of Xctr1 and 1 ng of
-galactosidase RNA was injected, as shown.
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morphogenesis. Injection of an Xmc-
speciﬁc morpholino (XmcMO) results
in a dose-dependent translational
block of a co-expressed Myc epitope-
tagged Xmc construct (Xmc-Myc) in
gastrula stage embryos (Fig. 5;
Frazzetto et al., 2002). This effect can-
not be mimicked with either a control,
“scrambled” morpholino (CMO), or
with an Xmc-speciﬁc morpholino con-
taining 5 base pair mismatches (Xm-
cMM; Fig. 5). Injection of XmcMO has
been previously shown to generate
three phenotypic classes by the tad-
pole stage: embryos with a kinked
axis, embryos with a short axis, and
embryos with an open blastopore
(Class I, II, and III, after Frazzetto et
al., 2002). In our hands, dorsal mar-
ginal injection of 25 ng of XmcMO at
the four-cell stage results in 87% of
embryos with Class II defects, with
the remainder exhibiting Class III de-
fects (N  15). This dose of XmcMO
was used for subsequent Xmc loss-of-
function studies.
Explant assays were used to test for
the potential requirement for Xmc in
Xctr1 knockdown-mediated morpho-
genesis. Elongation of FGF-treated
animal cap explants is enhanced fol-
lowing Xctr1 knockdown (Fig. 6A,B)
(Haremaki et al., 2007); this elonga-
tion is signiﬁcantly inhibited by co-
injection of the Xmc-speciﬁc morpho-
lino XmcMO (Fig. 6A,C). Inhibition of
Xctr1 knockdown-mediated elonga-
tion is not seen after injection of a 5
base pair mismatch Xmc morpholino
(XmcMM; Fig. 6D); moreover, the
block to inhibition by XmcMO can be
partially rescued by co-injection of
Xmc RNA lacking the XmcMO binding
site (Xmc), pointing to the speciﬁcity
of XmcMO for the Xmc transcript in
these assays (Fig. 6A,E). Xmc knock-
down does not, however, inhibit elon-
TABLE 1. Candidate Mediators of Ctrl-Independent Morphogenesis
ID Symbol Name Fold change
XI.5274.1.S1_at DasraA chromosomal passenger complex protein Dasra A 7.80
XI.585.1.S1_at ESR-6e enhancer of split related epidermal protein-6 6.74
XI.1262.1.S1_at LOC397921 nucleoplasmin 5.83
XI.1268.1.S1_at Otx2 homeobox protein 4.80
XI.973.1.S1_at LOC397824 homeobox protein Xgbx-2 4.34
XI.5454.1.S2_at Xmc marginal coil Xmc 4.15
XI.446.1.S1_at xlZPA vitelline envelope 69/64 kDa glycoprotein 3.88
XI.5888.2.S1_at rGAP rho-GTPase activating protein 3.67
XI.869.1.S2_at LOC397936 POU-domain protein 3.65
XI.11672.1.A1_at Otx2 homeobox protein 3.65
XI.798.1.S1_at B4 histone H1-like maternal protein 3.56
XI.7590.2.A1_at LOC397951 XDCoH 3.44
XI.5288.1.S1_at LOC398163 cyclin B4 3.42
XI.25540.3.A1_at LOC398660 KH domain RNA-binding protein Sam68 3.41
XI.699.1.S1_s_at LOC397948 VENT-2 transcription factor 3.41
XI.2582.1.S1_at rgma repulsive guidance molecule A protein phosphatase 1D
magnesium-dependent, delta
3.31
XI.8340.2.A1_a_at ppm1d isoform 3.27
XI.15540.2.A1_at atf5 activating transcription factor 5 3.23
XI.8719.1.S1_at dynII2 dynein light chain 2 3.20
XI.17481.1.A1_at mthfd2 methylene tetrahydrofolate dehydrogenase
(NADdependent), methenyltetrahydrofolate
cyclohydrolase
3.13
XI.15540.1.A1_at atf5 activating transcription factor 5 3.13
XI.1592.1.A1_at LOC397824 homeobox protein Xgbx-2 3.12
XI.8701.1.S1_a_at aldoc aldolase C, fructose-bisphosphate 3.11
XI.7590.2.A1_x_at LOC397951 XDCoH 3.07
XI.23306.1.S1_at cldn6 claudin 6 3.05
aList of Xenopus laevis transcripts with expression up-regulated at least threefold in ﬁbroblast growth factor (FGF)-treated animal
cap explants from embryos injected with a Ctrl-speciﬁc morpholino (XctrlMO). Only annotated genes are listed.
Fig. 4. Reverse transcriptase-polymerase
chain reaction (RT-PCR) analysis of Xmc ex-
pression during early Xenopus development.
Xmc expression is zygotic, and coincides with
diminishment of maternal Xctr1 transcripts.
Fig. 5. XmcMO inhibits translation of 3 Myc-
tagged Xmc RNA (Xmc-Myc) containing the
XmcMO binding site. Xmc-Myc translation is
not inhibited by co-injection of a ﬁve base pair
mismatch Xmc morpholino (XmcMM), or a con-
trol scrambled morpholino (CMO). Western blot
of protein lysates from stage 10 Xenopus em-
bryos, injected as listed, using anti-Myc and
anti--tubulin antibodies, as shown (Sigma).
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gation of animal caps by Activin (Fig.
6F); thus, Xmc is required for FGF-
mediated, Xctr1-independent morpho-
genesis.
DISCUSSION
The presence or absence of the trans-
membrane protein Ctr1 dictates the
interpretation of FGF receptor activa-
tion as, respectively, either a pro-dif-
ferentiation or a pro-morphogenesis
cue. Here, we demonstrate that Xmc is
a critical component of the signaling
cascade activated by FGF in the ab-
sence of Xctr1, as Xmc loss-of-function
inhibits Xctr1 knockdown-mediated
morphogenesis. This functional link is
buttressed by the temporal patterns of
expression of the two genes: the initi-
ation of Xmc expression at gastrula
stages correlates with the initial de-
cline in maternal Xctr1 expression lev-
els, and also with the initiation of
FGF-mediated morphogenesis.
Xmc represents one of more than
two dozen genes whose expression is
induced following Xctr1 knockdown; it
was selected for further analysis be-
cause it was the only transcript that
was also suppressed following Xctr1
misexpression in ectodermal explants.
We have found, however, that Xctr1
misexpression, despite inhibiting ex-
plant and embryo elongation, does not
block Xmc expression in the presence
of FGF or Activin (this study, andHare-
maki et al., 2007). This suggests that,
although Xmc is required for Xctr1-in-
dependent, FGF-mediated elongation,
Xmc suppression does not underlie
Xctr1-dependent inhibition of mesoder-
mal elongation; early suppression of
Xmc may, however, play a role in the
inhibition of neural morphogenesis by
Xctr1. Other candidates from our
screens, perhaps including factors that
are not required for mediating Xctr1-
independent morphogenesis, may be in-
volved in the suppression of premature
mesodermal morphogenesis down-
stream of Xctr1 (Haremaki et al., 2007);
we are beginning to test, in gain- and
loss-of-function assays, microarray tar-
gets whose expression is altered by
Xctr1 RNA, but not Xctr1 morpholino,
injection.
EXPERIMENTAL
PROCEDURES
Gene Chip Analysis
RNA from 80 animal cap explants,
cultured to stage 20, were used to gen-
erate hybridization probes for use on
Affymetrix GeneChip Xenopus laevis
Genome Arrays; hybridization was
performed with the help of the Mount
Sinai Microarray Shared Research Fa-
Fig. 6. Effects of Xmc loss-of-function on explant morphogenesis. A: Injection of morpholinos
against Xmc (XmcMO) inhibits Xctr1 knockdown-mediated morphogenesis in ﬁbroblast growth
factor (FGF) -treated animal cap explants at stage 22; this effect is rescued by co-expression of
Xmc RNA (Xmc) that lacks the XmcMO binding site. B–E: Quantiﬁcation of the requirement for Xmc
on explant morphogenesis. Error bars represent the standard error of the mean. y-axis  ratio of
cap length:cap width. B: Xctr1 knockdown increases elongation of FGF-treated animal caps. For
FGF, N  17; for FGF/Xctr1MO, N  19, with N  number of caps assayed. C: Xmc knockdown
inhibits Xctr1 knockdown-mediated elongation. For FGF/Xctr1MO, N  19; for FGF/Xctr1MO/
XmcMO, N  18. D: XmcMM does not inhibit Xctr1 knockdown-mediated elongation. For FGF/
Xctr1MO/XmcMO, N  25; for FGF/Xctr1MO/XmcMM, N  26. E: Suppression of Xctr1 knock-
down-mediated elongation by XmcMO is rescued by co-expression of Xmc RNA lacking the
XmcMO binding site (Xmc). For FGF/Xctr1MO/XmcMO, N  58; for FGF/Xctr1MO/XmcMO/Xmc,
N  57. F: Xmc knockdown does not affect Activin-mediated elongation. For Activin, N  8; for
Activin/XmcMO, N 9. *P 0.005; **P 0.01. A total of 10 ng/ml bFGF, and 0.5 ng/ml Activin was
added, as shown. Also, 2 ng of Xmc RNA, 250 ng of Xctr1MO, 25 ng of XmcMO, and 25 ng of
XmcMM were injected, as shown.
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cility (http://www.mssm.edu/research/
resources/microarray/). One nanogram
of Xctr1 or -galactosidase RNA, 250 ng
of Xctr1MO or 250 ng of Xctr1MM mor-
pholinos were injected, as described.
Microarray data were normalized by
RMA (Irizarry et al., 2003) and ana-
lyzed using the affylmGUI Bioconduc-
tor package (Wettenhall et al., 2006).
Normalized data were visualized by
MeV4.0 (Saeed et al., 2003).
Xmc Cloning and Mutant
Construction
An Image clone containing the Xenopus
marginal coil (Xmc) gene was obtained
from Open Biosystems (IMAGE ID:
6634521; accession no. BC072122). The
full coding sequence of Xmc was ampli-
ﬁed by PCR and cloned into the EcoRI
and XhoI sites of pCS2. For Xmc-
Myc, 16 base pairs of 5-untranslated
region (UTR) and the coding sequence
of Xmc was subcloned upstream of six
Myc (EQKLISEEDLNEM) epitopes in
the CS2MT vector; this construct con-
tains the complete XmcMO binding
site. The Xmc construct used for mor-
pholino rescue experiments lacks all 5-
UTR and thus much of the XmcMO
binding site.
RNA Preparation, Explant
Dissection, and Cell Culture
RNA was synthesized in vitro in the
presence of cap analog using the mMes-
sage mMachine kit (Ambion). Microin-
jection, explant dissection, and cell cul-
ture were performed as described
(Hemmati-Brivanlou and Melton, 1994;
Wilson and Hemmati-Brivanlou, 1995).
RT-PCR
RT-PCR was performed as described
(Wilson and Hemmati-Brivanlou, 1995).
Primers used in this study are as fol-
lows: Xgbx2-U: 5-CCCTTGACAGAT-
TAGATCGG; Xgbx2-D: 5-CTCGCA-
CTATACTTCTGTCC; Nucleoplasmin-U:
5-AGCCTAAGCGAGTTGCTTTG;
Nucleoplasmin-D: 5-TAGACTGGC-
AATCGGAACTG; DasraA-U: 5-ACT-
ACTGCTCTAACCAGGTC; DasraA-D:
5-CTGTATCTCCTCTCAGTAGC;
ESR-6e-U: 5- GGCACAGGGCAATA-
CTGGT; ESR-6e-D: 5-CCCCACTTG-
GCATTATGTTC; VENT-2-U: 5-ACCC-
ACTAATGGAAACCCTG; VENT-2-D:
5- CACATGGCCCAATATTAGCC;
Otx2-U: 5-CGGGATGGATTTGTTGCA;
Otx2-D: 5- TTGAACCAGACCTGGACT;
Xmc-U: 5-CTGGTGTTACAGACCAA-
GGGG; Xmc-D: 5-ACCTGTGCTTTT-
GCCACTC; Xctr1-U: 5-GTGTGTCT-
GCTGGAAACTAAG; Xctr1-D: 5-
TTCCCGCGAAATCTTCAG; ODC-U:
5-AATGGATTTCAGAGACCA; ODC-D:
5-CCAAGGCTAAAGTTGCAG.
Morpholinos
Morpholino oligos (Gene Tools) were
heated for 5 min at 65°C, then
quenched on ice, before injection at
the two- or four-cell stage. XmcMO: TG-
CAGC(CAT)TATGTATATGTAAAAA;
XmcMM: TGgAGC(gAT)TATcTAaATc-
TAAAAA. Additional morpholino se-
quences are as described (Frazzetto et
al., 2002; Haremaki et al., 2007).
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